Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases.

Abstract

Identifying factors that influence problematic beliefs and behaviors related to pharmacotherapy may be useful for clinicians to improve the patients' adherence. The study aims to assess patients' beliefs about the necessity and concerns regarding pharmacotherapy in rheumatic diseases and attitude styles, and to investigate the association between clinical factors and negative beliefs about medication. A sample of 712 patients affected by Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis was enrolled. They were assessed using the Beliefs about Medicines Questionnaires-Specific (BMQ), the Simplified Disease Activity Index (SDAI), the Visual Analogue Scale for pain (VAS), the Chalder Fatigue Scale (CFQ) and the Health Assessment Questionnaire-Disability Index (HAQ-DI). The balance between benefits and costs in the BMQ-Specific was positive in the 79.4% of patients, negative in the 12.1% and equal in the 8.6%. SDAI, taking more than 5 medications, taking anti interleukin 6 (Anti-IL6) or biological disease-modifying antirheumatic drugs (bDMARDs), or targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs), pain, and fatigue were significantly associated to higher Concerns. Having a longer disease duration was significantly associated with a higher Necessity, together with the current pharmacological treatments and the disability. The multivariate regression models estimated that higher pain and fatigue were associated to higher Concerns (p < 0.001), while a longer disease duration (p < 0.001) and all pharmacological treatments for a rheumatologic disease (p = 0.001) were associated to higher Necessity levels. A high length of disease, a low level of remission, a high number of total medications, the prescription of an Anti-IL6/bDMARDs/tsDMARDs drug, a high level of pain, fatigue and disability identified patients potentially less adherent to pharmacotherapy to be carefully looked after by clinicians.

• Authors: Sarah Tosato, Chiara Bonetto, Alice Zanini, Riccardo Bixio, Martina Marchel, Giulio Pacenza, Isotta Galvagni, Doriana Cristofalo, Elena Fracassi, Antonio Carletto
• Journal: Scientific reports (Sci Rep) Vol. 12 Issue 1 Pg. 22603 (12 30 2022) ISSN: 2045-2322 [Electronic] England
• PMID: 36585438 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Antirheumatic Agents

Topics

• Humans
• Medication Adherence (psychology)
• Arthritis, Rheumatoid (drug therapy)
• Antirheumatic Agents (therapeutic use)
• Surveys and Questionnaires
• Fatigue (drug therapy)
• Pain (drug therapy)